新生儿甲状腺筛查:分析前变量对干血斑促甲状腺激素测定的影响
研究采用美国疾病控制与预防中心制备干血斑性能测试标准的程序,生成血细胞比容35%至65%、血清促甲状腺激素(TSH)浓度为6.3±0.4与26.6±8.0 mIU/L的干血斑,用泰国公共卫生部新生儿筛查操作中心酶联免疫吸附试验测定洗脱TSH。线性混合效应模型显示血细胞比容显著影响干血斑TSH测定(p<0.001)。
要点
- 血细胞比容显著影响干血斑促甲状腺激素测定(p<0.001)。
- 血细胞比容每增加1%,洗脱TSH在低浓度时降低0.06 mIU/L,在高浓度时降低0.21 mIU/L。
- 血细胞比容导致的分析前变异可能导致先天性甲状腺功能减退筛查的假阳性和假阴性结果。
核心结论
- 干血斑促甲状腺激素测定受血样血细胞比容显著影响。
- 血细胞比容导致的分析前变异独立于促甲状腺激素测定的灵敏度、特异度、精密度、重复性和参考区间。
- 血细胞比容对干血斑促甲状腺激素测定的影响具有临床相关性,可能解释先天性甲状腺功能减退发病率的地理和种族差异,并可能导致先天性甲状腺功能减退筛查的假阳性和假阴性结果。
- 个体新生儿和人群特异性血细胞比容校正因子可能提高干血斑促甲状腺激素测定的精密度。
研究设计与样本
- 采用美国疾病控制与预防中心制备干血斑性能测试标准的程序,生成血细胞比容为35%、40%、45%、50%、55%、60%和65%且血清促甲状腺激素浓度为6.3±0.4和26.6±8.0 mIU/L的干血斑。
- 在每个血细胞比容下,用泰国公共卫生部新生儿筛查操作中心酶联免疫吸附试验测定四个重复3 mm干血斑打孔的洗脱液中的促甲状腺激素。
- 数据采用线性混合效应模型分析。
主要发现
- 基于混合效应模型,血细胞比容显著影响干血斑促甲状腺激素测定(p<0.001)。
- 当促甲状腺激素为6.3±0.4 mIU/L时,血细胞比容每增加1%,洗脱促甲状腺激素降低0.06 mIU/L。
- 当促甲状腺激素为26.6±8.0 mIU/L时,血细胞比容每增加1%,洗脱促甲状腺激素降低0.21 mIU/L。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Measuring thyrotropin (TSH) eluted from a dried blood spot (DBS) is used to screen an estimated 30 million newborns annually for congenital hypothyroidism (CH). Newborn thyroid screening has eliminated cretinism from the industrialized world and decreased the adverse effects of unrecognized CH on neurocognitive development. Hematocrit, a pre-analytic variable that affects the measurement of TSH from a DBS, contributes to the imprecision of DBS TSH measurement and could account for false-negative and false-positive DBS newborn screening test results. To assess whether variations in hematocrit found in newborns have a clinical effect in DBS-based newborn thyroid screening, the effects of hematocrit variability on the measurement of DBS TSH were studied. METHODS: U.S. Centers for Disease Control and Prevention procedures for manufacturing DBS performance testing standards were used to generate DBSs from blood samples, with hematocrits of 35%, 40%, 45%, 50%, 55%, 60%, and 65% and serum TSH concentrations of 6.3 ± 0.4 and 26.6 ± 8.0 mIU/L. TSH was measured in the eluates of four replicate DBS 3 mm punches at each hematocrit using the Thailand Ministry of Public Health Newborn Screening Operation Center enzyme-linked immunosorbent assay. Data were analyzed using a linear mixed-effects model. RESULTS: Based on the mixed-effects model, hematocrit significantly affected DBS TSH measurement (p < 0.001). A 1% increase in hematocrit resulted in a 0.06 mIU/L decrease in eluate TSH when TSH was 6.3 + 0.4 mIU/L, and a 0.21 mIU/L decrease in eluate TSH when TSH was 26.6 + 8.0 mIU/L. CONCLUSIONS: DBS TSH is significantly affected by the blood sample hematocrit. The pre-analytic variability due to hematocrit is independent of TSH assay sensitivity, specificity, precision, repeatability, and reference intervals. The effect of hematocrit on DBS TSH measurement is clinically relevant, could account for geographic and ethnic variation in the incidence of CH, and may result in both false-positive and false-negative CH screening results. Individual newborn and population-specific hematocrit correction factors may improve the precision of DBS TSH measurement.
引用
- Butler AM, Charoensiriwatana W, Krasao P, et al. Newborn Thyroid Screening: Influence of Pre-Analytic Variables on Dried Blood Spot Thyrotropin Measurement. Thyroid. 2017. PMID: 28810813. doi:10.1089/thy.2016.0452
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。